跳至主要内容
临床试验/IRCT20220209053979N9
IRCT20220209053979N9已完成Unknown

Bioequivalence Study of Sertraline 50 mg tablet manufactured by Shafa Pharmaceutical and Zoloft manufactured by Pfizer in 24 Healthy Volunteers under fasting condition

Shafa Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Healthy male or female volunteers
  • Body mass index (BMI) between 18 - 30
  • Volunteers who are willing to sign an informed consent form

排除标准

  • Familial history of heart disease
  • History of allergy to Sertraline or formulation components
  • Taking any type of medicine in the 14 days before the start of the study
  • Participation in any clinical study within 30 days prior to study

研究者

发起方
Shafa Pharmaceutical Company

相似试验